Inhibikase Therapeutics, Inc. (IKT)
1.80
+0.04
(+2.27%)
USD |
NASDAQ |
Feb 23, 16:00
1.83
+0.03
(+1.67%)
After-Hours: 19:59
Inhibikase Therapeutics Total Assets (Quarterly) : 79.59M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Beta Bionics, Inc. | 328.74M |
| ACADIA Pharmaceuticals, Inc. | 1.331B |
| Agenus, Inc. | 233.89M |
| Alnylam Pharmaceuticals, Inc. | 5.026B |
| Savara, Inc. | 140.92M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 6.696M |
| Shareholders Equity (Quarterly) | 72.90M |
| Current Ratio | 11.67 |
| Net Debt Paydown Yield | 0.03% |